(b)(4).The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other similar incidents and/or complaints from this lot.The investigation was unable to determine a conclusive cause for the reported balloon rupture.It was reported that the device was prepped inside the anatomy.It should be noted that the coronary dilatation catheters (cdc), traveler rx, global, instructions for use (ifu) specifies: all air must be removed from the balloon and displaced with contrast prior to inserting into the body, otherwise, complications may occur.In this case, it is unknown if the ifu violation caused or contributed to the reported complaint.There is no indication of a product quality issue with respects to the design, manufacture, or labeling of the device.The nc traveler device is currently not commercially available in the us; however, it is similar to a device sold in the us.
|
It was reported that the procedure was performed to treat the right coronary artery that was 90% stenosed.The 3.0x12mm traveler balloon dilatation catheter was prepped (air aspiration) inside the anatomy prior to use.Pre-dilatation was attempted, however, the balloon ruptured at 12 atms during second inflation (the first inflation was at 10 atms).The device was removed without issue and replaced with a new same size traveler balloon to successfully continue the procedure.There were no adverse patient effects and no clinically significant delay in the procedure.No additional information was provided.
|